Tolosa & #8211;Hunt syndrome: Long-term outcome and role of steroid-sparing agents

Conclusions: Around 50% of patients with THS can have recurrence. Steroid-sparing agents appear to prevent recurrence. A prospective multicenter randomized controlled trial may help to evaluate the risk and benefits of steroid-sparing therapy and to identify any possible predictors for recurrence.
Source: Annals of Indian Academy of Neurology - Category: Neurology Authors: Source Type: research